| AARD Shares Outstanding History Table | ||||||||||||
Below is a table of the AARD shares outstanding history going back to 5/1/2025:
Also see: AARD Market Cap History AARD YTD Return |
AARD Shares Outstanding History — Aardvark Therapeutics Share Count Over Time
As of 4/30/2026 Aardvark Therapeutics has 21.82 million AARD shares outstanding. Investors often track the AARD shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows AARD share count trends over time, with 5 historical shares outstanding datapoints presented, dating back to 5/1/2025.
| AARD Shares Outstanding History Chart | |||||||||||||
AARD Historical Shares Outstanding: +0.56% CAGR 
Mouse over chart for data details
| |||||||||||||
| AARD Stock Price Chart |
| About Aardvark Therapeutics Inc |
| Aardvark Therapeutics is a clinical-stage biopharmaceutical focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for treating metabolic diseases. Co. focused on developing Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Initial compounds target TAS2Rs expressed in the gut lumen, which normally respond to the nutrients in food and participate in the gut-brain axis. Co. lead product candidate, ARD-101 (denatonium acetate monohydrate), is an oral gut-restricted small-molecule agonist of certain TAS2Rs for which Co. initiated a Phase 3 clinical trial for hyperphagia associated with Prader-Willi Syndrome (PWS). We show 5 historical shares outstanding datapoints in our coverage of AARD's shares outstanding history. Understanding the changing numbers of AARD shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like AARD versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching AARD by allowing them to research AARD shares outstanding history as well as any other stock in our coverage universe. |
| AARD Current Stock Quote |
Quotes delayed 20 minutes  Free AARD Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| AARD Share Performance |
| Shares Outstanding Peers |
| Aardvark Therapeutics (AARD) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ABAX Shares Outstanding History ABBV Shares Outstanding History ABC Shares Outstanding History ABEO Shares Outstanding History ABIO Shares Outstanding History ABMD Shares Outstanding History ABOS Shares Outstanding History ABSI Shares Outstanding History ABT Shares Outstanding History ABVC Shares Outstanding History More Healthcare companies » |
AARD Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
